Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma. Michaelson MD, McKay RR, Werner L, Atkins MB, Van Allen EM, Olivier KM, Song J, Signoretti S, McDermott DF, Choueiri TK.Cancer. 2015 Oct 1;121(19):3435-43. [Epub 2015 Jun 8]. doi: 10.1002/cncr.29503.

Autor: Jay, Raman, McKay, RR, Werner, L, Atkins, MB, Van Allen, EM, Olivier, KM, Song, J, Signoretti, S, McDermott, DF, Choueiri, TK
Zdroj: In Urologic Oncology: Seminars and Original Investigations March 2017 35(3):117-118
Databáze: ScienceDirect
Externí odkaz: